copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Adcock Ingram At Adcock Ingram our mission is to provide quality products across a range of therapeutic areas that improve healthcare, now and in the future This is how we are adding value to life
Product information :: Adcock Ingram Product information Our mission at Adcock Ingram is to deliver high quality products that enhance the health and well-being of all South Africans
Company profile :: Adcock Ingram Adcock Ingram is a Proudly South African company, and a leading South African pharmaceutical 1 manufacturer Founded over 130 years ago in 1891, the Company is listed on the Johannesburg Stock Exchange and its extensive portfolio of products includes well-known household brands like Panado, Allergex, Epi-max, Citro-Soda and Myprodol
Adcock Ingram Adcock Ingram offers a diverse range of career opportunities in the pharmaceutical manufacturing sector Explore our current vacancies and join us in improving the health and lives of people in our communities
GROUP ANNUAL FINANCIAL STATEMENTS - adcock. com Adcock Ingram Holdings Limited is incorporated and domiciled in South Africa, where its ordinary shares are publicly traded on the Securities Exchange of the JSE Limited
Adcock Ingram Adcock Ingram is a leading South African pharmaceutical manufacturer listed on the Johannesburg Stock Exchange The Company manufactures, markets, and distributes a wide range of healthcare products and is a leading supplier to both the private and public sectors of the market
CORPORATE SOCIAL RESPONSIBILITY 2023 - adcock. com Adcock Ingram funds the initiatives targeting the impoverished communities of Diepsloot, Kya Sands, and Lion Park, increasing access to quality primary healthcare services in these areas Patients benefit from mental health services, women’s health services and chronic disease management
We are pleased with the overall performance for the year, particularly . . . announcement on 23 July 2025, Adcock Ingram has entered into a Transaction Implementation Agreement (TIA) with NATCO Pharma Subject to the fulfilment of regulatory and shareho der approvals, NATCO Pharma will acquire all the shares in the Group, not owned by Bidvest, through a scheme of arrangement Adcock Ingram will subsequently be delist